Epidemiology of Vaginal candidiasis and Its Antifungal Susceptibility Pattern at the Buea Regional Hospital in Cameroon

Nicoline Fri Tanih *

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Cameroon.

Leudja Nathalie Flore

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Cameroon.

Luma Woquan Sama

Department of Biomedical Sciences, Faculty of Health Sciences, University of Buea, Cameroon.

Ofon Elvis Amih

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Cameroon.

Tanih Godfred Ngu

Department of Biotechnology and Food Technology, Faculty of Science, University of Johannesburg, Private Bag 2028, Johannesburg, South Africa.

Samie Amidou

Department of Biochemistry and Microbiology, University of Venda, Private Bag X5050 Thohoyandou, South Africa.

Chethkwo Fabrice

Department of Public Health Faculty of Health Sciences, University of Buea, Cameroon.

Njunda Anna Longdoh

Department of Medical Laboratory Sciences, Faculty of Health Sciences, University of Buea, Cameroon.

*Author to whom correspondence should be addressed.


Aims: This study aimed to assess the prevalence of Vulvovaginal candidiasis (VVC) and investigate the antifungal susceptibility patterns among both pregnant and non-pregnant women in Buea, Cameroon.

Study Design:  Cross-sectional hospital-based design.

Place and Duration of Study: The study was conducted at the Buea Regional Hospital, in the South West Region of Cameroon for a period of 3months.

Methodology: The study included a total of 270 participants, comprising 135 pregnant women and 135 non-pregnant women. Vaginal swab samples were collected and cultured on Sabouraud Dextrose Agar supplemented with chloramphenicol and later sub-cultured on Chromogenic Candida Agar. A Germ tube test was carried out to confirm the presence of Candida albicans and served as a confirmatory test in classifying the species as pathogenic or not. Kirby-Bauer disk diffusion technique was used for antimicrobial susceptibility testing. Statistical analysis was performed where a P <0.05 was considered significant.

Results: The overall prevalence of VVC was 20.7%. The prevalence was higher among pregnant women (23.7%) compared to non-pregnant women (17.8%). Candida albicans 69.6% was the most prevalent species while C. tropicalis (5.4%) was the least. Predisposing factors such as history of candidiasis was associated with VVC in pregnant women (P=0.009), while the presence of symptoms (P=0.011), and clothing preferences like trousers (P=0.048) were associated with VVC in non-pregnant women. Voriconazole (66.15%) was the most effective antifungal drug while caspofungin (81.25%) was least effective to all species.

Conclusion: VVC has a higher prevalence in pregnant than in non-pregnant women with Candida albicans, being the most prevalent species. History of candidiasis, presence of symptoms, and clothing preferences like trousers were statistically associated with the presence of VVC in this study population. Voriconazole could serve as the drug of choice for management of VVC infection.

Keywords: Vulvovaginal candidiasis, pregnant and non-pregnant women, predisposing factors

How to Cite

Tanih, Nicoline Fri, Leudja Nathalie Flore, Luma Woquan Sama, Ofon Elvis Amih, Tanih Godfred Ngu, Samie Amidou, Chethkwo Fabrice, and Njunda Anna Longdoh. 2024. “Epidemiology of Vaginal Candidiasis and Its Antifungal Susceptibility Pattern at the Buea Regional Hospital in Cameroon”. International Journal of TROPICAL DISEASE & Health 45 (7):68-79. https://doi.org/10.9734/ijtdh/2024/v45i71561.


Download data is not yet available.


Sobel JD. Recurrent vulvovaginal candidiasis. Am J Obstet Gynecol. 2016;214(1):15–21. PMID: 26164695.

da Silva Dantas A, Lee KK, Raziunaite I, Schaefer K, Wagener J, Yadav B, et al. Cell biology of Candida albicans–host interactions. Curr Opin Microbiol. 2016;34:111–8.DOI: 10.1016/j.mib.2016.08.006

Sellam A, Whiteway M. Recent advances on Candida albicans biology and virulence. F1000Res. 2016;5:2582.

Belayneh M, Sehn E, Korownyk C. Recurrent vulvovaginal candidiasis. Can Fam Physician. 2017;63(6):455.

Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: A systematic review. Lancet Infect Dis. 2018;18(11):e339– e347.DOI: 10.1016/S1473-3099(18)30103-8

Donders G, Sziller IO, Paavonen J, Hay P, de Seta F, Bohbot JM, et al. Management of recurrent vulvovaginal candidosis: Narrative review of the literature and European expert panel opinion. Front Cell Infect Microbiol. 2022;1257.

Okonkwo NJ, Umeanaeto PU. Prevalence of vaginal candidiasis among pregnant women in Nnewi Town of Anambra State, Nigeria. African Research Review. 2010;4(4).

Waikhom SD, Afeke I, Kwawu GS, Mbroh HK, Osei GY, Louis B, et al. Prevalence of vulvovaginal candidiasis among pregnant women in the Ho municipality, Ghana: Species identification and antifungal susceptibility of Candida isolates. BMC Pregnancy Childbirth. 2020 Dec;20(1):266.DOI: 10.1186/s12884-020-02963-3

Matheson A, Mazza D. Recurrent vulvovaginal candidiasis: A review of guideline recommendations. Aust N Z J Obstet Gynaecol. 2017;57(2):139–45.DOI: 10.1111/ajo.12592

Oviasogie FE, Okungbowa FI. Candida species amongst pregnant women in Benin City, Nigeria: Effect of Predisposing Factors. Afr J Clin Exp Microbiol. 2009;10(2):92–8.

Toua V, Djaouda M, Gaké B, Menye DE, Akoachere E, Tambe E, et al. Prevalence of vulvovaginal candidiasis amongst pregnant women in Maroua (Cameroon) and the sensitivity of Candida albicans to extracts of six locally used antifungal plants. Int Res J Microbiol. 2013;4(3):89-97.

Ane-Anyangwe L, Meriki HD, Silum SP, Nsongomanyi FR, Zofou D. Antifungal susceptibility profiles and risk factors of vaginal candidiasis amongst female university students in southwest region, Cameroon. Afr J Clin Exp Microbiol. 2015;16(2):67–72.

Salehei Z, Seifi Z, Mahmoudabadi A. Sensitivity of vaginal isolates of Candida to eight antifungal drugs isolated from Ahvaz, Iran. Jundishapur J Microbiol. 2012; 5(4):574–7.

Africa CW, dos Santos Abrantes PM. Candida antifungal drug resistance in sub-Saharan African populations: A systematic review. F1000Research. 2016;5.

Oli AN, Ugwu CB, Osuala EO, Oguejiofor CB, Eleje GU, Osuala FN, Ugwu MC. Antibiogram of vulvovaginal candidiasis amongst pharmacy undergraduates in a Nigerian University. Journal of Advances in Medicine and Medical Research. 2017;22(12):1–10.Available:https://doi.org/10.9734/JAMMR/2017/33340

Hingankar Y, Taksande V. Screening and risk factor associated with vulvovaginal candidiasis among pregnant women, Journal of Pharmaceutical Research International. 2021;33(41B):1–6.DOI: 10.9734/jpri/2021/v33i41B32338

Sobel JD, Faro S, Force RW, Foxman B, Ledger WJ, Nyirjesy PR, Reed BD, Summers PR. Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations. American Journal of Obstetrics and Gynecology. 1998 Feb 1;178(2):203-11.

Irene VR, Sajeeth CI, Karthikeyan V, Sabitha J. Assessment of risk factors for developing vulvovaginal candidiasis among women at various age groups. Biosci Biotech Res Asia. 2023;20(1).

Irene VR, Sreeja PA, Dawn VJ, Karthikeyan V, Kadar KAA. Quality of life among women with vulvovaginal candidiasis in a tertiary care centre in India. Biotech Res Asia 2023;20(4).

Fon FL. Housing standards, household health and disease nexus in the Buea municipality. J Sustain Dev. 2014;7(4):262.

Kechia FA, Dohbit JS, Kouotou EA, Iwewe SY, Dzoyem JP, Mbopuwouo NM, et al. Profil épidémiologique et étiologique de la candidose vulvo-vaginale chez la femme enceinte à Yaoundé (Cameroun). Health Sci. Dis. 2015;16(4).

Kountchou CL, Milaine TEO, Velhima A, Noubom M, Kechia FA, Ngueguim A, et al. Vulvo-vaginal candidiasis in pregnant women at the bafoussam regional hospital (West Region Of Cameroon) And Susceptibility of Isolates to Antifungals. BJMHS. 2021;3(1).

Al-akeel RA, El-kersh TA, Al-Sheikh YA, Al-Ahmadey ZZ. Prevalence and comparison for detection methods of Candida species in vaginal specimens from pregnant and non-pregnant Saudi women. Afr. J. Microbiol. Res. 2013;7(1):56–65.

Ibrahim SM, Bukar M, Mohammad Y, Audu BM, Ibrahim HM. Prevalence of vaginal candidiasis among pregnant women with abnormal vaginal discharge in Maiduguri. Niger J Med. 2013;22(2):138–42.

Alo MN, Anyim C, Onyebuchi AK, Okonkwo EC. Prevalence of asymptomatic co-infection of candidiasis and vaginal trichomoniasis among pregnant women in Abakaliki, South-Eastern Nigeria. Prevalence. BJMLS. 2012;2(7):87–91.

Jombo GTA, Opajobi SO, Egah DZ, Banwat EB, Akaa PD. Symptomatic vulvovaginal candidiasis and genital colonization by Candida species in Nigeria. J Public Health Epidemiol. 2010;2(6):147–51.

Khan M, Ahmed J, Gul A, Ikram A, Lalani FK. Antifungal susceptibility testing of vulvovaginal Candida species among women attending antenatal clinic in tertiary care hospitals of Peshawar. Infect Drug Resist. 2018;11:447–56.

Kombade SP, Abhishek KS, Mittal P, Sharma C, Singh P, Nag VL. Antifungal profile of vulvovaginal candidiasis in sexually active females from a tertiary care hospital of Western Rajasthan. J Fam Med Prim Care. 2021;10(1):398.

Ekpenyong CE, Inyang-etoh EC, Ettebong EO, Akpan UP, Ibu JO, Daniel NE. Recurrent vulvovaginal candidosis among young women in south eastern Nigeria: The role of lifestyle and health-care practices. Int J STD AIDS. 2012; 23(10):704–9.

Disha T, Haque F. Prevalence and risk factors of vulvovaginal Candidosis during pregnancy: A review. Infect Dis Obstet Gynecol. 2022;2022:6195712.

Paulitsch A, Weger W, Ginter‐Hanselmayer G, Marth E, Buzina W. A 5‐year (2000–2004) epidemiological survey of Candida and non‐ Candida yeast species causing vulvovaginal candidiasis in Graz, Austria. Mycoses. 2006; 49(6):471–5.

Tsega A, Mekonnen F. Prevalence, risk factors and antifungal susceptibility pattern of Candida species among pregnant women at Debre Markos Referral Hospital, Northwest Ethiopia. BMC Pregnancy Childbirth. 2019; 19(1):527.

Jasim ST. The relationship between vulvovaginal candidiasis and some predisposing factors in prevalence among Baghdad women. Sys Rev Pharm. 2020;11(12):1318–22.

Xu J, Sobel JD. Candida vulvovaginitis in pregnancy. Curr Infect Dis Rep. 2004;6(6):445–9.